Skip to main content

Popper and Co. to Present New Framework for Economic Evaluation of Diagnostics in the Era of Precision Medicine at Next Generation Dx Summit

By August 20, 2018News
popper-and-company-logo

popper-and-company-logo

Popper and Co., a strategy consulting and transaction advisory firm serving the needs of the medical technology and life sciences industries, announced today that Co-Founder and President Caroline Popper, M.D., will speak at the 10th Annual Next Generation Dx Summit on August 22 at 5 pm ET at the Grand Hyatt Washington in Washington, DC.

{iframe}https://www.prnewswire.com/news-releases/popper-and-co-to-present-new-framework-for-economic-evaluation-of-diagnostics-in-the-era-of-precision-medicine-at-next-generation-dx-summit-300696704.html?tc=eml_cleartime{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.